Prof. Dr. Meral Beksaç

Internal medicine and hematology

Biology and treatment of plasma cell disorders

Clinical research

Stem cell transplantation and other cellular therapies

Cord blood and natural killer (NK) cell biology

Ankara Science High School — Graduation, June 1974

Hacettepe University Faculty of Medicine — Medical Degree, June 1980

Hacettepe University Faculty of Medicine — Residency in Internal Medicine, November 1985

Associate Professorship in Internal Medicine, October 1987

Ankara University Faculty of Medicine — Fellowship in Hematology, September 1991

Ankara University — Professorship in Hematology, July 1993

Istinye University — Faculty Member, 2024

Liv Hospital Ankara, 2023–Present

Ankara University Faculty of Medicine, Division of Hematology — Faculty Member, 1989–2023

Ankara University Unrelated Donor Tissue and Cord Blood Bank — Founder and Faculty Director, 2006–2023

Ankara University Tissue Typing Laboratory — Founding Director, 1995–2023

Member, Turkish Academy of Sciences, 1995–Present

Member, Science Academy, 2011–Present

President, Turkish Bone Marrow Transplantation Foundation, 2012–Present

Member, International Myeloma Foundation Scientific Advisory Board, 1999–Present

Board Member, European Myeloma Network, 2023–Present

Vice President, Balkan Myeloma Study Group, 2018–Present

Vice Chair, EBMT CMWP Plasma Cell Disorders Committee

Chair, Turkish Society of Hematology Multiple Myeloma Subcommittee, 2022–Present

Advances in Hematology — Editorial Board

Frontiers in Medicine — Associate Editor

Frontiers in Genetics — Guest Editor

Clinical Lymphoma, Myeloma & Leukemia — Editorial Board

Frontiers in Pharmacology — Editorial Board

European Blood and Marrow Transplantation Group (EBMT), since 1991

International Bone Marrow Transplantation Registry (IBMTR), since 1992

International Society of Hematology (ISH), since 1992

European Hematology Association (EHA), since 1994

EORTC Leukemia Cooperative Group, since 1991

Turkish Society of Hematology, since 1990

Turkish Bone Marrow Transplantation Foundation — Founding Member and Board President

American Society for Transplantation and Cellular Therapy, since 2008

American Society of Hematology (ASH), since 1991

International Myeloma Foundation, since 2000

European Federation for Immunogenetics (EFI), since 2000

World Marrow Donor Association (WMDA), since 2000

European Myeloma Network — Founding Member, since 2004

International Myeloma Society, since 2009

Balkan Myeloma Study Group, since 2017

EHA Congress Scientific Committee — Member, 2014–2017

TÜBİTAK Service Award, 2024

Ankara University Most Successful Academic of the Year, 2021

Visiting Professorship Award, Nanjing Municipal Hospital of TCM, China, 2018

Best Basic Science Abstract in Multiple Myeloma, New York, USA, 2017

Kaymakçalan Science Award, Turkish Cancer Research and Control Association, 1986

Third Prize, TÜBİTAK Project Competition, 1973

Beksac M, Mastanzade M, Bostankolu Degirmenci B, et al. 2026 Myeloma Treatment Guidelines of the Turkish Myeloma Study Group. Clin Lymphoma Myeloma Leuk. Published online 15 August 2026. DOI: 10.1016/j.clml.2026.08.008.

Vural E, Ocal R, Aytekin H, Aksoyoğlu İ, Nevruz O, İlhan O, Beksac M. Non-cryopreserved hematopoietic stem cell transplantation compared to conventional autologous peripheral stem cell transplantation with cryopreserved stem cells among patients newly diagnosed with myeloma. Transfusion and Apheresis Science. 2026;65(4):104493. DOI: 10.1016/j.transci.2026.104493.

Vural E, Beksac M. 2025 Update of Cellular Immunotherapy for Plasma Cell Disorders. Turk J Hematol. 2026;43(1):1–17. DOI: 10.4274/tjh.galenos.2025.2025.0330.

Kastritis E, Beksac M, Badelita SN, et al.; Balkan Myeloma Study Group. VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG). Clin Lymphoma Myeloma Leuk. 2025;25(2):e71–e81. DOI: 10.1016/j.clml.2024.08.007.

Beksac M. Daratumumab maintenance in patients with myeloma. Lancet Oncology. 2024;25(8):947–948. DOI: 10.1016/S1470-2045(24)00341-3.

Beksac M, Cengiz Seval G, Kanellias N, et al. A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome. Haematologica. 2020;105(1):201–208. DOI: 10.3324/haematol.2019.219295.